AIM ImmunoTech (AIM) Stock: Buy, Sell, or Hold?
AIM - AIM ImmunoTech Inc.
$0.16
0.00 (-2.92%)
▼
5d:
-7.02%
30d:
-23.12%
90d:
-37.48%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 16, 2026
22d
Get Alerted When AIM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: AIM shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: AIM shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: AIM is currently trading at $0.16, which is considered oversold relative to its 30-day fair value range of $0.17 to $0.21.
Technical Outlook: Technically, AIM is in a downtrend. Immediate support is located at $0.15, while resistance sits at $0.18.
Market Sentiment: AIM scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.25 (+2619.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AIM is in a downtrend. Immediate support is located at $0.15, while resistance sits at $0.18.
Market Sentiment: AIM scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.25 (+2619.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.17 -
$0.21
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 2619.1% below Wall St target ($4.25)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.17 -
$0.21
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.15
Resistance Level
$0.18
Current Trend
Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.42
Wall Street Target
$4.25
(+2619.1%)
Revenue Growth (YoY)
4.0%
Share & Embed Analysis
Last updated: October 23, 2026 10:13 PM ET
Data refreshes hourly during market hours. Next update: 11:12 PM
Data refreshes hourly during market hours. Next update: 11:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AIM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$258 | 61 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$72 | 48 HOLD |
